(Press-News.org) Fox Chase Researchers Develop a New Tool That Helps Identify Prostate Cancer Patients with the Highest Risk of Death
MIAMA BEACH, FL (October 4, 2011)––After a prostate cancer patient receives radiation treatment, his doctor carefully monitors the amount of prostate-specific antigen, or PSA, in his blood. An increase in PSA, called biochemical failure, is the first detectable sign of the cancer's return to the prostate. Fox Chase Cancer Center researcher have found that the time between the last radiation treatment and biochemical failure can accurately predict a patient's risk of death of prostate cancer.
Now, Mark Buyyounouski, M.D., M.S., a radiation oncologist at Fox Chase, has led the development a new tool, called a nomogram, that can be used to estimate the risk of dying from prostate cancer for patients who have already had radiation treatment. Buyyounouski introduced the new tool at the 53rd Annual Meeting of the American Association for Radiation Oncology on Sunday, October 2.
It's the first tool of its kind; existing nomograms do not factor in the interval between radiation and biochemical failure. Nomograms already exist to help newly-diagnosed patients and their doctors decide on a treatment, but the new tool provides information about patients who have already undergone radiation.
Buyyounouski and his international team of collaborators built and tested the nomogram using data from 2,132 men who had biochemical failure. The data came from five institutions in three countries. In addition to the time to biochemical failure, the nomogram uses other factors such as the patient's age, tumor-stage, Gleason score, and PSA charateristics, to calculate risk of death. The researchers describe the comparison between the test's predicted survival rates and experimental observations as "excellent."
Patients who are told they're in biochemical failure often face tough questions about the risk of dying from cancer that are difficult to answer. "We haven't had really had much information to help guide us," Buyyounouski says. "But, we've learned that the sooner a patient experiences biochemical failure after the completion of radiation treatment, the more likely it is that he is going to develop metastases and die of prostate cancer. This new tool uses that information to predict the risk of death on an individual basis."
"With this nomogram, a practitioner can plug in various factors, including the the PSA level, Gleason score, tumor stage, and interval to biochemical failure to get an estimate of the five- and 10-year risk of death. It's a very useful tool."
"The decision to start a new treatment is often difficult to make becuae patients almost always have no symptoms when the PSA levels return. If a patient knew they had a 50% risk of dying of prostate cancer in the next 5 years may make the decision easier," Buyyounouski added
"This tool is also useful for research who are interested in exploring new prostate cancer treatments, before it has had a chance to spread. The nomogram can identify patients at the highest risk of dying." "Unfortunately, patients who have PSA recurrence but no evidence of spread," Buyyounski says, "are often overlooked in clinical trials of new treatments."
For Buyyounouski, the test is a culmination of years of research establishing the validity of using time to biochemical failure as a way of predicting risk of death in prostate cancer patients. He and his collaborators are adapting their work to create an online version of the tool that will be freely available to the public. The tool will be available at the Fox Chase Cancer Center web site early next year.
###
Study co-authors include Larry Kestin (William Beaumont, Royal Oak, MI,), Gillian Duchesne (Peter MacCallum Cancer Centre, East Melbourne, Australia), Tom Pickles (BC Cancer Agency, Vancouver, BC, Canada), Roger Allison (5Royal Brisbane & Women's Hospital, Brisbane, Australia), and Scott Williams (Peter MacCallum Cancer Centre, East Melbourne, Australia).
Fox Chase Cancer Center is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at www.foxchase.org or call 1-888-FOX CHASE or (1-888-369-2427).
END
MIAMA BEACH, FL (October 4, 2011)––In a new study led by Fox Chase Cancer Center radiation oncologist Natasha Townsend, M.D., researchers have found that Gleason scores determined by pathologists at Fox Chase Cancer Center more accurately predict the risk of recurrence than Gleason scores from referring institutions. She presented the new research at the 53rd Annual Meeting of the American Society for Radiation Oncology on Monday, October 3.
When a man is diagnosed with prostate cancer, his tumor is assigned a Gleason score – a number between 2 and 10 indicating the ...
DENVER (Oct. 5, 2011) – A new study shows that using the Internet to look for a job reduces the time spent unemployed by an average of 25 percent.
The discovery directly contradicts a 2004 study showing that using the Internet actually prolonged unemployment.
"In 2004 the researchers came up with two scenarios for their findings – the Internet was not an effective tool or that people who looked on-line for jobs were not as qualified," said Hani Mansour, Ph.D., assistant professor of economics at the University of Colorado Denver who conducted the new study with Peter ...
More than 100 artefacts from the First World War have been uncovered in an archaeological fieldwork survey on the Gallipoli battlefield, leading to some interesting theories about life on the frontline according to University of Melbourne survey archaeologist Professor Antonio Sagona.
The discoveries were made as part of a second season of fieldwork undertaken as part of the Joint Historical and Archaeological Survey – the only systematic survey of the battlefields of Gallipoli since the First World War.
The survey covered the northern frontline areas on the Turkish ...
A new insight into global photosynthesis, the chemical process governing how ocean and land plants absorb and release carbon dioxide, has been revealed in research that will assist scientists to more accurately assess future climate change.
In a paper published today in Nature, a team of US, Dutch and Australian scientists have estimated that the global rate of photosynthesis, the chemical process governing the way ocean and land plants absorb and release CO2, occurs 25% faster than previously thought.
From analysing more than 30 years of data collected by Scripps Institution ...
Interactive video games, already known to improve motor function in
recovering stroke patients, appear to safely enhance physical therapy
for patients in intensive care units (ICU), new research from Johns
Hopkins suggests.
In a report published online in the Journal of Critical Care,
researchers studied the safety and feasibility of using video games to
complement regular physical therapy in the ICU.
"Patients admitted to our medical intensive care unit are very sick and,
despite early physical therapy, still experience problems with muscle
weakness, balance ...
"Too busy," and "too complicated." These are the typical excuses one might expect when medical professionals are asked why they fail to use online error-reporting systems designed to improve patient safety and the quality of care. But, Johns Hopkins investigators found instead that the most common reason among radiation oncologists was fear of getting into trouble and embarrassment.
Investigators e-mailed an anonymous survey to physicians, nurses, radiation physicists and other radiation specialists at Johns Hopkins, North Shore- Long Island Jewish Health System in New ...
A team of scientists, led by Johns Hopkins researchers, say they may have found a way to predict how quickly patients with Alzheimer's disease (AD) will lose cognitive function by looking at ratios of two fatty compounds in their blood. The finding, they say, could provide useful information to families and caregivers, and might also suggest treatment targets for this heartbreaking and incurable neurodegenerative disorder.
Past research has shown that cognitive function declines at different rates in AD patients, with roughly one-third not declining at all in five years, ...
A new study from the University of Adelaide shows the parents of women with polycystic ovary syndrome (PCOS) are more likely to have some form of cardiovascular disease.
PCOS is a hormonal disorder affecting about 10% of women of reproductive age. It is one of the most common endocrine disorders in women and a leading cause of infertility.
The study shows mothers of women with PCOS are more likely to have any form of cardiovascular disease, and almost twice as likely to have high blood pressure, than mothers of other women.
Fathers of women with PCOS are more than ...
ST. PAUL, Minn. – People who rate their health as poor or fair appear to be significantly more likely to develop dementia later in life, according to a study published in the October 5, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Having people rate their own health may be a simple tool for doctors to determine a person's risk of dementia, especially for people with no symptoms or memory problems," said study author Christophe Tzourio, MD, PhD, director of the Inserm unit 708 Neuroepidemiology at the University of Bordeaux ...
STANFORD, Calif. -- North American babies who acquire toxoplasmosis infections in the womb show much higher rates of brain and eye damage than European infants with the same infection, according to new research from the Stanford University School of Medicine.
Eighty-four percent of the North American infants studied had serious complications of the parasitic infection, including calcium deposits in the brain, water on the brain and eye disease that caused visual impairment or blindness. By contrast, few European infants had these problems -- for instance, about 17 percent ...
